 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
6 September 2005 | Volume 143 Issue 5 | Pages 317-326
Background: Patients with chronic obstructive pulmonary disease (COPD) frequently develop exacerbations, leading to major clinical and health resource use ramifications.
Objective: To prospectively evaluate the effectiveness of a long-acting inhaled anticholinergic bronchodilator, tiotropium, in reducing COPD exacerbations and exacerbation-related health care utilization.
Design: Randomized, double-blind study.
Setting: 26 Veterans Affairs medical centers.
Patients: 1829 patients with moderate to severe COPD (mean baseline FEV1, 36% predicted).
Intervention: Once-daily tiotropium (18 µg) or placebo for 6 months. Patients otherwise received usual care, except for other anticholinergic bronchodilators.
Measurements: The coprimary end points were the percentage of patients with a COPD exacerbation and the percentage of patients with a COPD-related hospitalization.
Results: Tiotropium significantly reduced the percentage of patients experiencing 1 or more exacerbations compared with placebo (27.9% vs. 32.3%, respectively; difference, –5.7 percentage points [95% CI, –10.4 to –1.0 percentage points]; P = 0.037). Fewer tiotropium patients were hospitalized because of COPD exacerbation (7.0% vs. 9.5%, respectively; difference, –3.0 percentage points [CI, –5.9 to –0.1 percentage points]; P = 0.056), although this difference was of borderline statistical significance. Analysis of secondary outcomes indicates that tiotropium may lengthen the time to first COPD exacerbation (P = 0.028) and reduce health care utilization for exacerbations, including the frequency of hospitalizations (P = 0.047), unscheduled clinic visits (P = 0.019), and days of antibiotic treatment (P = 0.015). Tiotropium did not statistically significantly reduce all-cause hospitalization rates.
Limitations: Trial participants were enrolled from 1 health care system, and 99% were men. The follow-up period extended for only 6 months.
Conclusions: Tiotropium reduces COPD exacerbations and may reduce related health care utilization in patients with moderate to severe COPD.
Editors' Notes
Context
Contribution
Cautions
–The Editors
Author and Article Information
From the Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota; Bay Pines Veterans Affairs Medical Center, Bay Pines, Florida; Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut.
Acknowledgments: The authors recognize the contributions of the trial investigators, co-investigators, and study staff (Appendix); P. Arnold, B. Caldwell, S. Johnson, J. Tallman, and D. Chow; and the Duke Clinical Research Institute (which managed the data); and the Minnesota Veterans Research Institute (which furnished administrative support for all study centers).
Grant Support: By Boehringer Ingelheim and Pfizer, Inc.
Potential Financial Conflicts of Interest: Employment: L. Korducki, C. Cassino, S. Kesten (Boehringer Ingelheim Pharmaceuticals); Consultancies: D.E. Niewoehner (Boehringer Ingelheim Pharmaceuticals, Chiron Corp., AstraZeneca, Aventis, Sanofi Pasteur), C. Cote (Boehringer Ingelheim Pharmaceuticals); Honoraria: D.E. Niewoehner (Boehringer Ingelheim Pharmaceuticals), K. Rice (Boehringer Ingelheim Pharmaceuticals), J.A.D. Cooper Jr. (Boehringer Ingelheim Pharmaceuticals); Grants received: D.E. Niewoehner (Boehringer Ingelheim Pharmaceuticals, Chiron Corp., Sanofi Pasteur), K. Rice (Boehringer Ingelheim Pharmaceuticals), C. Cote (Boehringer Ingelheim Pharmaceuticals), D. Paulson (Boehringer Ingelheim Pharmaceuticals); Grants pending: C. Cote (Boehringer Ingelheim Pharmaceuticals).
Requests for Single Reprints: Dennis E. Niewoehner, MD, Pulmonary Section (111N), Veterans Affairs Medical Center, One Veterans Drive, Minneapolis, MN 55417; e-mail, niewo001{at}umn.edu.
Current Author Addresses: Drs. Niewoehner and Rice: Pulmonary Section (111N), Veterans Affairs Medical Center, One Veterans Drive, Minneapolis, MN 55417.
Dr. Cote: Respiratory Diseases (111A), Veterans Affairs Medical Center, PO Box 5005, Bay Pines, FL 35294.
Dr. Paulson: Sanofi-Aventis Research, 9 Great Valley Parkway, Malvern, PA 19355.
Dr. Cooper: Veterans Affairs Medical Center, Pulmonary Division/215 THT, 1900 University Boulevard, Birmingham, AL 35294.
Mr. Korducki and Drs. Cassino and Kesten: 900 Ridgebury Road, Ridgefield, CT 06877.
Author Contributions: Conception and design: D.E. Niewoehner, K. Rice, J.A.D. Cooper Jr., S. Kesten.
Analysis and interpretation of the data: D.E. Niewoehner, K. Rice, D. Paulson, J.A.D. Cooper Jr., L. Korducki, C. Cassino, S. Kesten.
Drafting of the article: D.E. Niewoehner, K. Rice, D. Paulson, L. Korducki, C. Cassino, S. Kesten.
Critical revision of the article for important intellectual content: D.E. Niewoehner, K. Rice, C. Cote, D. Paulson, J.A.D. Cooper Jr., C. Cassino, S. Kesten.
Final approval of the article: D.E. Niewoehner, K. Rice, C. Cote, D. Paulson, J.A.D. Cooper Jr., C. Cassino, S. Kesten.
Provision of study materials or patients: K. Rice, D. Paulson, J.A.D. Cooper Jr.
Statistical expertise: L. Korducki.
Obtaining of funding: D.E. Niewoehner, J.A.D. Cooper Jr., S. Kesten.
Administrative, technical, or logistic support: D.E. Niewoehner, C. Cote, C. Cassino, S. Kesten.
Collection and assembly of data: D.E. Niewoehner, D. Paulson. ARTICLE
Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator
A Randomized Trial
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D Singh, J Brooks, G Hagan, A Cahn, and B J O'Connor Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD Thorax, July 1, 2008; 63(7): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Todd, R. A. McIvor, S. O. Pugsley, and G. Cox Approach to chronic obstructive pulmonary disease in primary care Can Fam Physician, May 1, 2008; 54(5): 706 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Albert and P. M. A. Calverley Drugs (including oxygen) in severe COPD Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Suissa, P. Ernst, K. L. Vandemheen, and S. D. Aaron Methodological issues in therapeutic trials of COPD Eur. Respir. J., May 1, 2008; 31(5): 927 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. MacNee Update in Chronic Obstructive Pulmonary Disease 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oba Does Tiotropium Reduce Hospitalizations in Chronic Obstructive Pulmonary Disease? Ann Intern Med, April 15, 2008; 148(8): 626 - 626. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Braganza, R. Chaudhuri, and N. C. Thomson Review: Treating patients with respiratory disease who smoke Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 95 - 107. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Greenland, S. Lanes, and M. Jara Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation Clinical Trials, February 1, 2008; 5(1): 5 - 13. [Abstract] [PDF]
|
|
|
|
|
|
S D Aaron, D Fergusson, G B Marks, S Suissa, K L Vandemheen, S Doucette, F Maltais, J F Bourbeau, R S Goldstein, M Balter, et al. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials Thorax, February 1, 2008; 63(2): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Welte Acute Exacerbation of Chronic Obstructive Pulmonary Disease: More a Functional than an Inflammatory Problem? Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 130 - 131. [Full Text] [PDF]
|
|
|
|
|
|
G. R. Washko, V. S. Fan, S. D. Ramsey, Z. Mohsenifar, F. Martinez, B. J. Make, F. C. Sciurba, G. J. Criner, O. Minai, M. M. DeCamp, et al. The Effect of Lung Volume Reduction Surgery on Chronic Obstructive Pulmonary Disease Exacerbations Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 164 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vijayasaratha and R. A. Stockley Reported and Unreported Exacerbations of COPD: Analysis by Diary Cards Chest, January 1, 2008; 133(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha, P. M. A. Calverley, T. A. Seemungal, G. Hagan, Z. Ansari, R. A. Stockley, and for the INSPIRE Investigators The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Rennard and T. Higenbottam Exacerbation-Free COPD: A Goal Too Far? Proceedings of the ATS, December 1, 2007; 4(8): 583 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Qaseem, V. Snow, P. Shekelle, K. Sherif, T. J. Wilt, S. Weinberger, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, November 6, 2007; 147(9): 633 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wilt, D. Niewoehner, R. MacDonald, and R. L. Kane Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline Ann Intern Med, November 6, 2007; 147(9): 639 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kesten, M. Plautz, C. A. Piquette, M. P. Habib, and D. E. Niewoehner Premature discontinuation of patients: a potential bias in COPD clinical trials Eur. Respir. J., November 1, 2007; 30(5): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Hanania and J. F. Donohue Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: Bronchodilators Proceedings of the ATS, October 1, 2007; 4(7): 526 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Powrie, T. M. A. Wilkinson, G. C. Donaldson, P. Jones, K. Scrine, K. Viel, S. Kesten, and J. A. Wedzicha Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Eur. Respir. J., September 1, 2007; 30(3): 472 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Naylor, D. Bakstad, M. Biffen, B. Thong, P. Calverley, S. Scott, C. A. Hart, R. J. Moots, and S. W. Edwards Haemophilus influenzae Induces Neutrophil Necrosis: A Role in Chronic Obstructive Pulmonary Disease? Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Criner Optimal Treatment of Chronic Obstructive Pulmonary Disease: The Search for the Magic Combination of Inhaled Bronchodilators and Corticosteroids Ann Intern Med, April 17, 2007; 146(8): 606 - 608. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Aaron, K. L. Vandemheen, D. Fergusson, F. Maltais, J. Bourbeau, R. Goldstein, M. Balter, D. O'Donnell, A. McIvor, S. Sharma, et al. Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease: A Randomized Trial Ann Intern Med, April 17, 2007; 146(8): 545 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Gelb, C. F. Taylor, P. A. McClean, C. M. Shinar, M. T. Rodrigues, C. A. Gutierrez, K. R. Chapman, and N. Zamel Tiotropium and Simplified Detection of Dynamic Hyperinflation Chest, March 1, 2007; 131(3): 690 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J R Hurst and J A Wedzicha What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines Thorax, March 1, 2007; 62(3): 198 - 199. [Full Text] [PDF]
|
|
|
|
|
|
P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Niewoehner, Y. Lokhnygina, K. Rice, W. G. Kuschner, A. Sharafkhaneh, G. A. Sarosi, P. Krumpe, K. Pieper, and S. Kesten Risk Indexes for Exacerbations and Hospitalizations Due to COPD Chest, January 1, 2007; 131(1): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Brusasco Reducing cholinergic constriction: the major reversible mechanism in COPD Eur. Respir. Rev., December 1, 2006; 15(99): 32 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. O'Donnell Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance Eur. Respir. Rev., December 1, 2006; 15(99): 37 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rodriguez-Roisin Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Eur. Respir. Rev., December 1, 2006; 15(99): 47 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Decramer Tiotropium as essential maintenance therapy in COPD Eur. Respir. Rev., December 1, 2006; 15(99): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Heffner Update in pulmonary medicine. Ann Intern Med, November 21, 2006; 145(10): 765 - 773. [Full Text] [PDF]
|
|
|
|
|
|
R G Barr, J Bourbeau, C A Camargo, and F S F Ram Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis Thorax, October 1, 2006; 61(10): 854 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Knight and S. D. Fihn Update in General Internal Medicine Ann Intern Med, July 4, 2006; 145(1): 52 - 61. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe Update in chronic obstructive pulmonary disease 2005. Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
S Scott, P Walker, and P M A Calverley COPD exacerbations {middle dot} 4: Prevention Thorax, May 1, 2006; 61(5): 440 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dusser, M-L. Bravo, P. Iacono, and on behalf the MISTRAL study group The effect of tiotropium on exacerbations and airflow in patients with COPD. Eur. Respir. J., March 1, 2006; 27(3): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. O'Connor Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium Ann Intern Med, January 17, 2006; 144(2): 148 - 148. [Full Text] [PDF]
|
|
|
|
|
|
C. B. Good and L. Longo Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium Ann Intern Med, January 17, 2006; 144(2): 147 - 147. [Full Text] [PDF]
|
|
|
|
|
|
G. M. Turino Therapeutic Gains of Prolonged Bronchial Dilatation in Chronic Obstructive Pulmonary Disease Ann Intern Med, September 6, 2005; 143(5): 386 - 387. [Full Text] [PDF]
|
|
Read all Rapid Responses
Article
